48 studies found for:    Open Studies | "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
21 Recruiting A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
22 Unknown  Magnetic Resonance Imaging Follow-up on Temporomandibular Arthritis in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: Steroid injection into the TMJs.
23 Recruiting Long-Term Safety Study Of CP-690,550 In Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550
24 Recruiting Virtual Peer-to-Peer (VP2P) Support Mentoring for Juvenile Idiopathic Arthritis (JIA): A Pilot RCT
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: Virtual Peer-to-Peer Support Mentoring
25 Recruiting A Study of Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
26 Recruiting Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550
27 Recruiting Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Abatacept
28 Recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis, Rheumatoid Arthritis
Intervention: Drug: Tocilizumab [RoActemra/Actemra]
29 Recruiting Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis
Condition: Juvenile Idiopathic Arthritis Associated Uveitis
Intervention: Drug: Tocilizumab
30 Recruiting A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis (JIA)
Interventions: Drug: VIMOVO 250/20;   Drug: VIMOVO 375/20;   Drug: VIMOVO 500/20
31 Recruiting Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
Condition: Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
Intervention: Biological: Abatacept
32 Recruiting Pediatric Arthritis Study of Certolizumab Pegol
Condition: Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
Intervention: Drug: Certolizumab Pegol (CZP)
33 Unknown  Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: intra-articular steroid injection
34 Not yet recruiting "Medikidz Explain JIA Comic Book- Hebrew"
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: reading comics booklet
35 Unknown  Use of Thermal and 3D Imaging to Quantify Arthritis
Conditions: Rheumatoid Arthritis;   Juvenile Rheumatoid Arthritis
Intervention: Other: 3D and thermal imaging
36 Unknown  PRINTO (the Paediatric Rheumatology International Trials Organisation)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: methotrexate
37 Recruiting The CARRA Registry
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Mixed Connective Tissue Disease;   Juvenile Ankylosing Spondylitis;   Juvenile Dermatomyositis;   Localized Scleroderma;   Systemic Sclerosis;   Vasculitis;   Sarcoid;   Fibromyalgia, Primary;   Auto-inflammatory Disease;   Idiopathic Uveitis Idiopathic
Intervention:
38 Recruiting Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
Conditions: Chronic Hepatitis B;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis;   Juvenile Idiopathic Arthritis
Interventions: Drug: Entecavir;   Drug: Placebo
39 Unknown  Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Juvenile Dermatomyositis
Intervention: Drug: Human papilloma virus vaccine (cervarix)
40 Recruiting Surveillance of Humira in Korean JIA Patients
Condition: Polyarticular Juvenile Idiopathic Arthritis
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-48) Show next page of results
Indicates status has not been verified in more than two years